Research progress in stem cell technology in Alzheimer's disease

Abstract

Abstract. Dementia in the elderly is a neurodegenerative disease that affects approximately 50-75% of people worldwide. Patients with Alzheimers will gradually experience a decline in intelligence and cognitive function, and Alzheimers is also the most common form of Alzheimers disease. At present, there have been many advances in the causes and treatment of Alzheimers disease, but they also face great difficulties. There is no effective treatment for senile dementia yet, and the main clinical drugs are to alleviate symptoms, delay onset, and reduce the impact of the disease on daily life. However, stem cell technology has made great progress this year, and stem cells have shown tremendous potential in the treatment of many diseases. Many studies have been conducted on the use of stem cells in the treatment of Alzheimers and Alzheimers disease, and some of the results have shown good therapeutic effects. The application of mesenchymal stem cells in the treatment of Alzheimers disease has been partially preclinical. However, most of the plans for treating dementia in the elderly through stem cell therapy are still in the experimental stage, and there is currently a lack of standardized treatment. There are potential risks and technical difficulties in promotion and implementation that need to be further explored. Further research is needed on the risks, processes, and technical difficulties of stem cell therapy. This article will systematically discuss the symptoms and pathogenesis of senile dementia, and analyze the current use of stem cells in the treatment of senile dementia. This article will contribute to peoples understanding of dementia in the elderly and promote related research.